Study wrapper · #953
Five primary melanomas in situ in a patient with recent tanning bed use, melanotan exposure, and anabolic hormone use.
Vadner DJ, Smith S JAAD case reports. 2026.
DOI: 10.1016/j.jdcr.2026.05.009PubMed: 42328529
Editor's note
This single case report describes multiple in-situ melanomas in a patient with several concurrent exposures, including melanotan, tanning beds, and anabolic hormones. With multiple confounding factors and a sample of one, it cannot attribute causation to any single agent. Relevant to the safety discussion around unregulated melanotan use, with appropriate caution about what a case report can show.
Plain-language abstract
A case report describes a patient who developed five early-stage melanomas after recent tanning bed use, melanotan exposure, and anabolic hormone use.
Related coverage
Weak / none
Unregulated Melanotan Use Promoted via Social Media: Emerging Dermatologic and Public Health Risks.
International journal of dermatologyn=——2026
Weak / none
Depigmented Facial and Neck Patches Following Melanotan Use in a Patient With Atopic Dermatitis and Alopecia Areata.
Clinical and experimental dermatologyn=——2026
Weak / none
Changes in Oral Mucosa Associated with Melanotan II Injections: A Case Report.
Life (Basel, Switzerland)n=——2026